Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Dana-Farber Cancer Institute is committed to providing expert, compassionate care.
(3794)

Dana-Farber Cancer Institute is committed to providing expert, compassionate care to children and adults with cancer, while advancing the understanding, treatment, cure, and prevention of cancer and related diseases.

Picture this: after finishing a test, a researcher carefully rinses a media bottle, or versatile lab container, that wou...
01/04/2026

Picture this: after finishing a test, a researcher carefully rinses a media bottle, or versatile lab container, that would otherwise be thrown away before dropping it into a bright, clearly labeled “Lab Plastics Recycling” bin. Across our wet labs, this is becoming a familiar sight thanks to the new lab-specific plastic recycling program from the Environmental, Health & Safety (EHS) team.

Launched in October 2025, the new program makes it easy for researchers and staff to recycle clean, non-hazardous plastics such as pipette tip boxes, media bottles, and more, into the new “Lab Plastics Recycling” bins complete with clear, lab-friendly signage. Beyond reducing landfill waste and our carbon footprint, the program promotes safer, cleaner labs and ensures compliance. It also provides valuable data to guide smarter, more sustainable purchasing, helping us take tangible steps toward a greener future.

We partnered with Polycarbin, a sustainability-focused company that operates within the life sciences and health care sector with the mission to create a circular economy for laboratory plastics, which are traditionally single-use and contribute significantly to plastic waste.

“With this partnership we can divert thousands of pounds of valuable plastic from entering our landfills which are projected to reach capacity within the next 10 to 20 years,” says Environmental Compliance and Sustainability Manager Michael Copponi. “Recycling lab plastics isn’t just important — it’s one of the simplest steps we can take to protect our planet while advancing science responsibly,” he continued.

As part of this new initiative, the EHS team provides monthly updates upon request on the total pounds of plastics recycled, including estimates of CO₂ emissions avoided and water and fossil fuels conserved. The reports also track and include relatable carbon equivalents, such as the number of miles driven, days running an -80°C freezer, or acres of forest protected.

“The value of data for Dana-Farber's sustainability is not merely in its collection, but in its responsible refinement and application, which drives actionable insights and positive change,” explains Copponi.

Join Hal Burstein, MD, PhD, for an educational session on new breast cancer research part of the 2025-2026 EMBRACE Metas...
01/02/2026

Join Hal Burstein, MD, PhD, for an educational session on new breast cancer research part of the 2025-2026 EMBRACE Metastatic Breast Cancer Forum, a series of free virtual educational programs for patients, families and loved ones.

Friday, January 16 | 3 - 4 p.m. ET

Learn more about the latest updates on treatment and research breakthroughs for metastatic breast cancer from the 2025 San Antonio Breast Cancer Symposium. A Q&A will follow the presentation.

For more information and to register, please visit https://bit.ly/4aGwLx4.

Because your experience matters. 💙
01/01/2026

Because your experience matters. 💙

12/31/2025

How much has cancer care changed in the first quarter of this century? Quite a lot, thanks to cancer research here and around the world. Get the details here: https://bit.ly/4pJ9Ju9

Clinical trials play a key role in advancing cancer treatment. Curious how clinical trials work? Swipe to learn more.
12/29/2025

Clinical trials play a key role in advancing cancer treatment. Curious how clinical trials work? Swipe to learn more.

12/28/2025

The call from the NMDP seemed to come from out of nowhere, but it bore some hopeful news: senior project manager Alexandria Monteiro’s stem cells were a match for a stranger with leukemia who needed a transplant.

“I don’t remember signing up,” Monteiro admits. According to the NMDP, she had done so 12 years ago while in college. “But based on who I know myself to be,” she continues, “it does sound like something I would have done.”

Despite the surprise, Monteiro came to her decision quickly. She could not pass up an opportunity to help cure someone’s leukemia. A stem cell transplant can be a lifesaving treatment. Some blood cancers originate from a malfunction in the stem cells.

For many leukemia cases, oncologists rely on a donation of someone else’s stem cells to essentially kickstart the immune system to fight the cancer. Donor stem cells need to be a close genetic match. Otherwise, the recipient’s immune system may reject them.

Sometimes, a relative can donate their stem cells, but in around 70 percent of cases no one in the family is a match. In those cases, physicians turn to the NMDP, a worldwide database of potential donors like Monteiro. Still, there aren’t always matches in the registry.

“That’s why it’s a no-brainer for me,” Monteiro says.

She chose to donate through our Donor Services because the act feels like an extension of her work in the Business Operations and Provider Services Department at Dana-Farber.

“This has come full circle,” she says. “What I signed up for 12 years ago is directly connected to what we do here day-to-day at Dana-Farber.”

The Donor Services Program takes a comprehensive approach to managing and collecting stem cell donations with dedicated advocates and clinical teams to ensure a donor’s health and safety.

Monteiro sat for seven hours as a machine collected her blood, removed the stem cells, and replaced it. For Monteiro, the time spent was nothing compared to the feeling that she has potentially changed a life.

“It’s an honor,” she says, reflecting on the experience. “It affirms to me that our deeds – regardless of how big or small you might think they are – can make an impact.”

Meet TT, the little troll with a big job. TT didn’t just bring joy to Jennifer’s treatment days. She also helped spark c...
12/26/2025

Meet TT, the little troll with a big job. TT didn’t just bring joy to Jennifer’s treatment days. She also helped spark conversations about triple-negative breast cancer. Through humor and creativity, Jennifer found a way to share her journey and spread joy to others during her care at Dana-Farber.

Read her full story: https://bit.ly/4qmbi0W

This and that around the Institute: Holiday Edition.
12/24/2025

This and that around the Institute: Holiday Edition.

Yawkey 10 infusion patients received a thoughtful gesture from former patient Dan Auger’s family ahead of the holidays. ...
12/22/2025

Yawkey 10 infusion patients received a thoughtful gesture from former patient Dan Auger’s family ahead of the holidays. Dan was a patient here for several years before passing away in the summer of 2024. During his treatment, he was incredibly touched by a gift bag he received from the Friends of Dana-Farber – and he and his family wanted to pay that gratitude forward. Dan’s sister, Katherine, came up with the idea, and he knew the plan was underway. Recently, she and Dan’s wife, Linda, proudly donated dozens of bags in his memory.

The totes were generously filled with fuzzy socks, blankets, journals, word puzzle books, playing cards, personal care items, affirmation cards and notes, and a rubber chicken – a nod to Dan’s sense of humor.

Dan’s message to everyone? “Until next time, be kind and try to make a stranger smile. You never know what someone else is going through. Love you all - Dan.” 💙

Thousands of riders rode Pan-Mass Challenge this year, each with their own story. For Kathy Ball-Toncic, the path to the...
12/21/2025

Thousands of riders rode Pan-Mass Challenge this year, each with their own story. For Kathy Ball-Toncic, the path to the starting line is one rooted in survival — and began on Sept. 11, 2001.

Kathy thought she had faced her worst fears that long-ago morning, running barefoot through glass-filled streets as the Twin Towers collapsed around her.

The experience prompted her to leave a successful financial services career and reinvent herself as a professional coach and “courage catalyst” — someone devoted to helping individuals and Fortune 500 companies create and embrace change. A breast cancer diagnosis on her 69th birthday in February 2023 was merely another challenge to get through, like the 11 marathons she had run for charity since 9/11.

But just a year later, came news that even the courage catalyst had a hard time grappling with. Less than two weeks after getting the “all clear” from her breast cancer team, Kathy learned the results of a recent colonoscopy.

She had colorectal cancer.

During a time of great uncertainty, the one thing Ball-Tonic was sure of was her next destination. Confident in the clinical care and warmth she had received during her breast cancer treatment, she returned to the place she thought she had left behind.

“I was going back to Dana-Farber,” says Kathy.

Once declared cancer-free again, in August 2024, Kathy began physical therapy. She soon realized that her long-distance running days had to be put on hold, but came up with another way to challenge herself athletically while helping others.

Kathy 's oncologist, Brandon Huffman, MD, and her physical therapist both embraced the idea, and she signed up for the 2025 PMC. This coming weekend, she will climb aboard her bike and begin a 162-mile, two-day trek from Wellesley to Provincetown. She expects to shed more than a few tears along the way — mostly of joy.

“Proof of life isn’t just about having a pulse,” Kathy wrote in a blog about her decision to ride the PMC. “It’s about choosing to live fully — with courage, vulnerability, and the occasional raised hand, especially when it’s trembling.”

Read Kathy's full story: https://bit.ly/4skgaps

For years, Shelly Sepulveda has shown up for others — first as a NICU nurse, then as a foster mom to more than 20 babies...
12/20/2025

For years, Shelly Sepulveda has shown up for others — first as a NICU nurse, then as a foster mom to more than 20 babies. Alongside her wife, Tami, she eventually adopted five of those children, building a home rooted in love, intention, and stability.

In 2024, her role shifted in an unexpected way. After a sudden trip to the ER, Shelly received a stage III ovarian cancer diagnosis and found herself becoming the one in need of care.

At Dana-Farber, she began an intense treatment journey with a team that truly heard her. From a complex HIPEC surgery to ongoing chemotherapy, Shelly has faced each step with remarkable courage, honesty, and grace.

Letting go of parts of her former identity — including her hair and her role as a nurse — hasn’t been easy. “It’s been a mental adjustment,” she shares. “But I’m leaning into getting to know this new version of myself.”

And now, the love she’s given so freely is coming back to her. Friends and neighbors are surrounding Shelly and her family with home-cooked meals, handwritten notes, and unwavering support.

Read Shelly's story: https://bit.ly/4qlf6Qo

“He told me I have breast cancer. It was the last thing I thought I’d hear,” recalls Michele Milso, who is currently fig...
12/20/2025

“He told me I have breast cancer. It was the last thing I thought I’d hear,” recalls Michele Milso, who is currently fighting metastatic breast cancer.

Within three months, she underwent a mastectomy, followed by eight rounds of chemotherapy. When scans revealed cancer in her lymph nodes, she then had 35 rounds of radiation. By November 2011, Michele completed her primary therapy and initiated adjuvant endocrine therapy — medication used to reduce the risk of breast cancer recurrence — for seven years.

About 11 years after her diagnosis, Michele thought something was wrong when her chin suddenly became numb. Evaluations revealed she had multiple areas of cancer in her skull. It was later determined that these findings indicated that Michele had metastatic breast cancer.

Upon receiving this news, Michele was unsure of how to proceed — and what lay ahead. Then, she reminded herself that “cancer wasn’t everything,” and she decided to take one step at a time —whatever that next step would be.

Since her diagnosis of metastatic breast cancer, Michele received standard cancer therapies. With her health and her drive to be there for her family in mind, at the next fork in the road for decision-making, Michele enrolled in a clinical trial — the evERA study — led by Erica Mayer, MD, MPH, director of Breast Cancer Clinical Research.

“Although we’ve made great progress in treating metastatic ER-positive, HER2-negative breast cancer, these cancers can become resistant to existing therapies, making them difficult to treat, such as in Michele’s case,” Dr. Mayer explains.

After having successful cancer control on the trial, Michele is now enrolled in a clinical trial of a triplet combination of endocrine therapy with two targeted therapies, led by Adrienne Waks, MD.

The new treatment protocol has had its challenges, but Michele is thankful she can continue to fight.

Read Michele’s full story: https://bit.ly/48J4JzQ

Address

Boston, MA

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Alerts

Be the first to know and let us send you an email when Dana-Farber Cancer Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram